关键词：基因组学；药物输送；RNA疗法；药物传递
摘 要：The increase in the understanding of genomics and drug delivery systems facilitated the development of RNA therapeutics as a mode of drug delivery. RNAi drug delivery systems offer better bioavailability and mode of action for effective therapeutic benefits. Three types of RNAi drug delivery technologies include the nanoparticle-based RNAi delivery system, the nucleicacid-based drug delivery method, and the aptamer-based RNAi drug delivery system. The nanoparticle-based RNAi drug delivery systems represent the most popular system; while the nucleic-acid-based drug delivery method and the aptamer-based RNAi drug delivery system represent the niche upcoming technologies.
目 录：

 01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Technology Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation

07.1 Overview

08. Geographical Segmentation

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

16.1 Competitive Scenario

16.1.1 Key News

16.1.2 Key Vendor

16.1.3 Prominent Vendors

17. Key Vendor Analysis

17.1 Alnylam Pharmaceuticals Inc.

17.1.1 Business Overview

17.1.2 Key Information

17.1.3 SWOT Analysis

17.2 Isis Pharmaceuticals Inc.

17.2.1 Business Overview

17.2.2 Key Information

17.2.3 SWOT Analysis

17.3 Merck & Co. Inc.

17.3.1 Business Overview

17.3.2 Business Segmentation

17.3.3 Key Information

17.3.4 SWOT Analysis

17.4 Tekmira Pharmaceuticals Corp.

17.4.1 Business Overview

17.4.2 Key Information

17.4.3 SWOT Analysis

18. Other Reports in this Series